Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

White matter hyperintensities are independently associated with systemic vascular aging and cerebrovascular dysfunction.

Webb A. et al, (2024), Int J Stroke

Cerebrovascular Effects of Sildenafil in Small Vessel Disease: The OxHARP Trial

Webb AJS. et al, (2024), Circulation Research, 135, 320 - 331

Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose-response and clinical efficacy of riociguat and selexipag using implanted technologies.

Varian F. et al, (2024), Pulm Circ, 14

Effect of blood pressure-lowering agents on microvascular function in people with small vessel diseases (TREAT-SVDs): a multicentre, open-label, randomised, crossover trial.

Kopczak A. et al, (2023), Lancet Neurol, 22, 991 - 1004

Associations between neurovascular coupling and cerebral small vessel disease: A systematic review and meta-analysis.

Yang S. and Webb AJS., (2023), Eur Stroke J

Consensus Recommendations for Standardized Data Elements, Scales, and Time Segmentations in Studies of Human Circadian/Diurnal Biology and Stroke

Saver JL. et al, (2023), Stroke

Association of gout with brain reserve and vulnerability to neurodegenerative disease

Topiwala A. et al, (2023), Nature Communications, 14

The EffecTs of Amlodipine and other Blood PREssure Lowering Agents on Microvascular FuncTion in Small Vessel Diseases (TREAT-SVDs) trial: Study protocol for a randomised crossover trial.

Kopczak A. et al, (2023), Eur Stroke J, 8, 387 - 397

Low-frequency oscillations in the brain show differential regional associations with severity of cerebral small vessel disease: a systematic review

Thomas J. et al, (2023), Frontiers in Neuroscience, 17

Consistencies and Differences in Intermediate Physiological Phenotypes of Vascular Ageing between Ischaemic Stroke Aetiologies

Webb AJS. et al, (2022), Cerebrovascular Diseases, 1 - 8

Framework for Clinical Trials in Cerebral Small Vessel Disease (FINESSE): A Review.

Markus HS. et al, (2022), JAMA Neurol

Low Heart Rate Is Associated with Cerebral Pulsatility after TIA or Minor Stroke.

Webb AJS. et al, (2022), Ann Neurol

Prevalence of stroke, associated risk factors and stroke related physical, mental, and economic burden in the Republic of Georgia

Akhvlediani T. et al, (2022), EUROPEAN STROKE JOURNAL

Aortic Stiffness, Pulse Pressure, and Cerebral Pulsatility Progress Despite Best Medical Management: The OXVASC Cohort

Webb AJS. et al, (2022), Stroke, 53, 1310 - 1317

New Insights Into Cerebrovascular Pathophysiology and Hypertension.

Webb AJS. and Werring DJ., (2022), Stroke

Blood Pressure Complexity Discriminates Pathological Beat-to-Beat Variability as a Marker of Vascular Aging.

Lee Y-K. et al, (2022), J Am Heart Assoc

European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack

Dawson J. et al, (2022), European Stroke Journal

Response to letter by Prof Christian Nolte and colleagues

Dawson J. et al, (2022), European Stroke Journal

Big cohort studies offer insights into preventable risk factors

Wartolowska KA. and Webb AJS., (2021), European Heart Journal, 42, 4280 - 4281

White matter damage due to pulsatile versus steady blood pressure differs by vascular territory: a cross-sectional analysis of the UK Biobank cohort study.

WARTOLOWSKA K., (2021), Journal of Cerebral Blood Flow and Metabolism

Load More

1
2
3
4
5

Include forthcoming?